But in an increasingly competitive market for weight loss drugs, these are not the only options for people looking to lose ...

A new class of weight loss drugs developed by Novo Nordisk and Eli Lilly “opens the possibility of an end to the obesity ...

Up to a third of the weight lost while taking weight loss jabs such as Wegovy and Mounjaro includes muscle and bone mass.

Ozempic has gotten most of the name recognition associated with weight-loss drugs, it's not the only drug in this category ...

Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...

We recently compiled a list of the 12 Best Weight Loss Stocks to Buy According to Hedge ... according to the WHO. A novel ...

We recently compiled a list of the 12 Best Weight Loss Stocks to Buy According to Hedge Funds. In this article, we are going ...

Novo Nordisk's stock suffered its biggest one-day slide on record after its latest obesity drug trial ... is nearly a best-case scenario for Lilly's tirzepatide (20.9% weight loss) given Novo's ...

The effects that a pause may have on your body may depend on why you're taking the medication in the first place.

Tiny doses of the weight-loss drug can sidestep its unpleasant side effects, say influencers. But is customising the dose a ...

Novo Nordisk A/S’s shares fell by the most on record after patients using its experimental obesity shot CagriSema lost less ...